ArticleBMC urology2023

Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder.

Roger R Dmochowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.